Blood clotting is characterized by complex pathways and individual variability. Incorporation of genetic information into the care of thrombotic disorders has shown promise. Personalized approach ...

Omeros (OMER) announced statistical analysis results related to the expanded access program for narsoplimab, Omeros’ ...

Omeros’ monoclonal antibody inhibiting the lectin pathway of complement, in the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy, a life-threatening ...